All clinical trials on the European Union Clinical Trials Register (EUCTR) must report their results in the registry within a year of completion. This site tracks who's doing this and who isn't. Learn more »
These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
| Status | Trial ID | Title | Completion date | Category |
|---|---|---|---|---|
| Completed, but no date Terminated | 2004-004620-12 | Assessment of normal release morphine in the management of dyspnoea | bad-data | |
| Ongoing | 2004-004707-38 | A multicentre randomised phase II clinical trial comparing oxaliplatin (Eloxatin), capecitabine (Xeloda) and pre-operative radiotherapy with or without cetuximab followed by total mesorectal excision ... | not-yet-due | |
| Ongoing | 2005-001660-31 | A Prospective Randomized Controlled Trial of Morphine versus Oxycodone for Cancer Pain: Genetic Determinants of Response to Opioids. | not-yet-due | |
| Exempt | 2005-002027-13 | A phase I/II study of docetaxel plus prednisolone plus diethylstilbestrol plus aspirin in androgen-independent prostate cancer | not-yet-due | |
| Exempt, with results | 2005-002715-24 | TARGET Trial: A Phase I-II dose finding and early efficacy study of combination therapy with erlotinib (tarceva), gemcitabine, bevacizumab (avastin) and capecitabine in advanced pancreatic cancer. | not-yet-due | |
| Ongoing | 2005-002736-10 | Open, Randomised Phase II Study Assessing The Toxicity And Efficacy Of Platinum-Based Chemotherapy With Vitamin Supplementation In The Treatment Of Lung Cancer | not-yet-due | |
| Exempt, with results | 2005-002801-22 | Carboplatin Plus Xeloda Followed By Maintenance Xeloda (CARBOX) | not-yet-due | |
| Ongoing | 2005-003795-37 | Response to Parenteral Morphine and Oxycodone in Acute Pain. | not-yet-due | |
| Reported results | 2005-004505-29 | Phase II clinical trial of capecitabine and oxaliplatin plus bevacizumab as neoadjuvant treatment for patients with previously untreated unresectable liver-only metastases from colorectal cancer | 2015-02-10 | due-trials |
| Ongoing | 2005-004508-35 | THE USE OF PET/CT SCANNING TO ASSESS EARLY RESPONDERS TO TARCEVA (ERLOTINIB): A PHASE II STUDY | not-yet-due | |
| Ongoing | 2005-006018-16 | A Randomised Phase III Trial Of Low Dose DailyDexamethasone Versus Intermittent Dexamethasone Versus Prednisolone In Hormone Refractory Prostate Cancer | not-yet-due | |
| Completed, but no date Terminated | 2006-000492-16 | A Phase II, Single-Centre, Randomised, Controlled, Open-Label Clinical Trial to Compare the Efficacy and Safety of Three Therapeutic Interventions on the Treatment of Hypothalamic Obesity due to Child... | bad-data | |
| Ongoing | 2006-000810-18 | A Randomised Study to Investigate the Effectiveness of Acupuncture for the Relief of Dyspnoea in Patients with Non-Small Cell Lung Cancer | not-yet-due | |
| Not reported Terminated | 2006-003844-41 | Feasibility study of R-CHOP plus bevacizumab in patients with diffuse large B cell lymphoma (DLBCL) | 2010-06-15 | due-trials |
| Not reported | 2006-004282-34 | A phase II study of bethanechol chloride to treat pseudomembranous candidosis in cancer patients with salivary gland dysfunction. | 2010-09-01 | due-trials |
| Exempt Terminated | 2006-004822-97 | A Phase I / II Trial to Evaluate the Combination of Infliximab and Sorafenib in the Treatment of Renal Cell Carcinoma | 2009-09-14 | not-yet-due |
| Reported results Terminated | 2006-006073-24 | CINATRA: Chromosomal Instability and Anti-Tubulin Response Assessment: A Phase II Study of Epothilone B in Metastatic Colon Carcinoma in patients with Microsatellite Instability or Chromosomal Instabi... | 2011-04-11 | due-trials |
| Ongoing | 2006-006615-80 | A Pilot Study in Metastatic Advanced Thyroid Cancer Evaluating the Safety and Efficacy of Sorafenib | not-yet-due | |
| Ongoing | 2007-000805-32 | AN INVESTIGATION INTO THE ROLE OF PARACETAMOL (ACETAMINOPHEN) AT STEP 3 OF THE WHO ANALGESIC LADDER | not-yet-due | |
| Ongoing | 2007-003877-21 | Trial of Perioperative Endocrine Therapy - Individualising Care (POETIC) | not-yet-due | |
| Ongoing | 2007-005976-15 | A randomised open-labelled multicentre trial of the efficacy of epirubicin, oxaliplatin and capecitabine (EOX) with or without panitumumab in previously untreated advanced oesophago-gastric cancer (RE... | not-yet-due | |
| Ongoing, reported early | 2008-000517-30 | A multicentre randomised phase II clinical study of UFT/leucovorin (LV), radiotherapy with or without cetuximab following induction gemcitabine plus capecitabine in patients with locally advanced panc... | not-yet-due | |
| Not reported Terminated | 2008-000524-82 | MESH: A Non-Randomised Phase II Trial of Methotrexate in Metastatic Colorectal Cancer with MSH2 Deficiency | 2012-04-16 | due-trials |
| Ongoing, reported early | 2008-004499-38 | A randomised double-blind placebo-controlled trial of the safety and efficacy of ethosuximide 250mg capsules for the management of chemotherapy-induced painful peripheral neuropathy. | not-yet-due | |
| Exempt | 2008-008676-13 | A Phase II Study Of Sunitinib And Low Dose Metronomic Cyclophosphamide In Advanced Renal Cell Cancer | not-yet-due | |
| Ongoing, reported early | 2009-012945-49 | A Phase II Trial of Nilotinib in the Treatment of Patients with c-KIT Mutated Advanced Acral and Mucosal Melanoma (NICAM) | not-yet-due | |
| Ongoing | 2010-021163-33 | A Phase II Trial of Cediranib in the Treatment of Patients with Alveolar Soft Part Sarcoma (CASPS). | not-yet-due | |
| Ongoing | 2010-021412-42 | Prospective randomised controlled trial to investigate the effectiveness of inhalers for the relief of breathlessness in patients with lung cancer and COPD | not-yet-due | |
| Ongoing | 2010-022416-40 | A Translational, proof of the concept, study Of Pre-operative Pazopanib in treatment-naive patients with resectable soft tissue Sarcomas (TOPPS) | not-yet-due | |
| Ongoing | 2011-000601-49 | TOPARP: Phase II Trial of Olaparib in Patients with Advanced Castration Resistant Prostate Cancer. | not-yet-due | |
| Ongoing | 2011-001793-26 | A Phase II Trial of Metformin and Axitinib in BRAF Mutated Advanced Melanoma | not-yet-due | |
| Ongoing | 2011-003718-18 | Proof-of-concept study of AZD 4547 in patients with FGFR1 or FGFR2 amplified tumours | not-yet-due | |
| Ongoing | 2011-004146-18 | Cyclophosphamide, doxorubicin, vincristine and prednisolone (CHOP) versus gemcitabine, cisplatin and methyl prednisolone (GEM-P) in the first line treatment Of T-cell Lymphoma, a multicentre randomis... | not-yet-due | |
| Ongoing | 2011-004562-16 | A Phase II Study of Axitinib in Patients with Metastatic Renal Cell Cancer Unsuitable for Nephrectomy | not-yet-due | |
| Ongoing | 2012-002620-32 | A randomised phase II study comparing LEnalidomide plus rituximab, GEmcitabine and methylprednisolone (LR-GEM) to rituximab, gemcitabine, methylprednisolone and cisplatiN (R-GEM-P) in second-line trea... | not-yet-due | |
| Exempt | 2012-003896-20 | TAX-TORC: A Phase I multi-centre trial of the combination of AZD2014 (dual TORC1 and TORC2 inhibitor) and weekly paclitaxel in patients with solid tumours | 2017-11-15 | not-yet-due |
| Ongoing | 2012-004211-31 | Randomised double-blind controlled phase II trial of Tocovid SupraBio in combination with pentoxifylline (PTX) in patients suffering long-term adverse effects of radiotherapy for pelvic cancer | not-yet-due | |
| Ongoing | 2013-000293-29 | A prospective, multi-centre, open label, non-randomised two stage phase II clinical trial evaluating the efficacy of abiraterone in patients with epithelial ovarian (including fallopian tube and prima... | not-yet-due | |
| Ongoing | 2013-001949-13 | An International Multicentre Open Label Randomised Phase II Advanced Anal Cancer Trial Comparing Cisplatin plus 5-fluorouracil versus Carboplatin plus Weekly Paclitaxel in Patients with Inoperable Loc... | not-yet-due | |
| Ongoing | 2013-004055-20 | A phase II randomised trial of biomarkers to assess (dose-) response in patients with metastatic castration resistant prostate cancer treated with radium-223. | not-yet-due | |
| Exempt | 2013-004091-34 | A randomised Phase II study of Enzalutamide (MDV3100) in combination with AZD5363 in Patients with Metastatic Castration - Resistant Prostate Cancer | not-yet-due | |
| Not reported Terminated | 2014-000845-64 | A multicentre randomised phase II study of aflibercept plus chemotherapy in patients with colorectal liver-only metastases deemed to be inoperable or unsuitable for upfront liver resection | 2015-03-10 | due-trials |
| Ongoing | 2014-000887-16 | A phase II randomised study evaluating the biological and clinical effects of the combination of palbociclib with letrozole as neoadjuvant therapy in post-menopausal women with ER+ primary breast canc... | not-yet-due | |
| Ongoing | 2014-001470-34 | Pilot institutional study evaluating 5-fluorouracil following radiation therapy in children and young adults with relapsed/refractory ependymoma. | not-yet-due | |
| Ongoing | 2014-003319-12 | Window study of the PARP inhibitor rucaparib in patients with primary triple negative or BRCA1/2 related breast cancer (RIO) | not-yet-due | |
| Ongoing | 2014-004065-25 | Randomised Phase II Trial of Pembrolizumab and Radiotherapy in Melanoma | not-yet-due | |
| Ongoing | 2014-005684-32 | [18F] DIHYDRO-TESTOSTERONE PET IMAGING IN PATIENTS WITH PROGRESSIVE PROSTATE CANCER | not-yet-due | |
| Ongoing | 2015-001605-14 | A Randomised, double-blind, placebo controlled, multi-centre phase II study to assess the Efficacy and safety of 2nd line Olaparib in combination with Paclitaxel, in Western patients with advanced gas... | not-yet-due | |
| Ongoing | 2015-003009-40 | Magnetic Resonance Tumour Regression Grade (mrTRG) as a Novel Biomarker to Stratify Management of Good And Poor Responders To Chemoradiotherapy: A Rectal Cancer Multicentre Randomised Control Trial | not-yet-due | |
| Ongoing | 2015-005525-39 | Proof-of-concept study of ibrutinib in c-MYC and HER2 amplified gastrooesophageal carcinoma | not-yet-due | |
| Ongoing | 2017-000370-10 | Avelumab plus fluoropyrimidine-based chemotherapy as adjuvant treatment for stage III dMMR or POLE exonuclease domain mutant colon cancer: A phase III randomised study. | not-yet-due | |
| Ongoing | 2017-001680-20 | Phase II study of ROS1 targeting with crizotinib in advanced E-cadherin negative, ER positive lobular breast cancer or diffuse gastric cancer | not-yet-due |